Company Filing History:
Years Active: 1992-1993
Title: Karin Eklind: Innovator in Lung Cancer Research
Introduction
Karin Eklind is a prominent inventor based in Riverside, CT (US). She has made significant contributions to the field of cancer research, particularly in the area of lung tumors. With a total of 2 patents, her work focuses on innovative methods to inhibit tumor growth.
Latest Patents
Eklind's latest patents include a method of inhibiting lung tumors using arylalkyl isothiocyanates. This method is particularly effective in reducing the multiplicity and incidence of lung tumors induced by exposure to tobacco-specific nitrosamines. The isothiocyanates involved in her research include 4-phenylbutyl isothiocyanate, phenylpentyl isothiocyanate, and phenylhexyl isothiocyanate. These compounds are synthesized through a process that involves adding hydrochlorides of specific amines to thiophosgene in an inert organic solvent. For comparison testing, oxo-pyridyl butyl isothiocyanate is synthesized by dissolving myosmine in HCl to obtain a hydrochloride salt, which is then processed in dry chloroform.
Career Highlights
Karin Eklind has established herself as a key figure in cancer research through her innovative approaches and dedication to improving treatment methods. Her work has the potential to significantly impact the lives of individuals affected by lung cancer.
Collaborations
Eklind has collaborated with notable researchers in her field, including Fung-Lung Chung and Stephen S. Hecht. These partnerships have enhanced her research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Karin Eklind's contributions to lung cancer research through her innovative patents demonstrate her commitment to improving health outcomes. Her work continues to inspire advancements in the field of oncology.